Five-year follow-up of three RCTs in 58 of 104 children with FASD (choline vs placebo at age 2.5–5.9): choline linked to medium-sized advantages in non-verbal IQ (9.1% better) and working memory (11.3%); no significant differences in mental health diagnoses.
Secondary analysisn = 58
Wozniak et al. Long-Term Neurodevelopmental Outcome Following Three Randomized Controlled Trials of Choline in Fetal Alcohol Spectrum Disorder (FASD)